SCHEMBL23084008

SCHEMBL23084008

CCSc1ccc(NC)nc1-c1nc2cc(C(F)(F)F)cnc2n1C

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.46
DDR1 Q08345 1/20 0.32
STIM1 Q13586 1/20 0.31
ORAI1 Q96D31 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18506139 0.88 POLB (0.48) POLBDDR1
SCHEMBL18506071 0.87 POLB (0.48) POLBDDR1
SCHEMBL30003688 0.86 POLB (0.47) POLBDDR1
SCHEMBL18627806 0.86 POLB (0.47) POLBDDR1
SCHEMBL18506134 0.86 POLB (0.47) POLBDDR1
SCHEMBL29431598 0.83 POLB (0.52) POLBDDR1
SCHEMBL14677239 0.83 POLB (0.52) POLBDDR1
SCHEMBL14676724 0.82 POLB (0.48) POLBDDR1
SCHEMBL29431603 0.82 POLB (0.48) POLBDDR1
SCHEMBL18506138 0.82 POLB (0.51) POLBDDR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210070753-A1 HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING AGENT CONTAINING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070753-A1 HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING AGENT CONTAINING SAME NR2C2, NR4A3, HCRTR1 POLB 4595/4885DDR1 3699/4885STIM1 4203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.